Pheneturide

DB13362

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 206.245
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

809 Data
Buprenorphine Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Hydrocodone Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Magnesium sulfate The therapeutic efficacy of Pheneturide can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Pheneturide may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Mirtazapine Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Orphenadrine Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Pramipexole Pheneturide may increase the sedative activities of Pramipexole.
Ropinirole Pheneturide may increase the sedative activities of Ropinirole.
Rotigotine Pheneturide may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Pheneturide.
Sodium oxybate Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Thalidomide Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Mefloquine The therapeutic efficacy of Pheneturide can be decreased when used in combination with Mefloquine.
Mianserin The therapeutic efficacy of Pheneturide can be decreased when used in combination with Mianserin.
Orlistat Orlistat can cause a decrease in the absorption of Pheneturide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Topotecan Pheneturide may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Pheneturide.
Tetracosactide The risk or severity of liver damage can be increased when Tetracosactide is combined with Pheneturide.
Ethanol Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Fluvoxamine The risk or severity of adverse effects can be increased when Pheneturide is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Pheneturide is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Pheneturide is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Pheneturide is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Pheneturide is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Pheneturide is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Pheneturide is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Pheneturide is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Pheneturide is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Pheneturide is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Pheneturide is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Pheneturide is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Pheneturide is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Pheneturide is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Pheneturide is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Pheneturide is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Pheneturide is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Pheneturide.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Pheneturide.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Pheneturide.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Pheneturide.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Pheneturide.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Pheneturide.
Cocaine The risk or severity of methemoglobinemia can be increased when Pheneturide is combined with Cocaine.
Quinidine The therapeutic efficacy of Pheneturide can be decreased when used in combination with Quinidine.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Pheneturide.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Pheneturide.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Pheneturide.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Pheneturide.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Pheneturide.
Zopiclone The risk or severity of adverse effects can be increased when Pheneturide is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Pheneturide.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Pheneturide.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Pheneturide.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pheneturide.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Pheneturide.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Pheneturide.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Pheneturide.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Pheneturide.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Pheneturide.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Pheneturide.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Pheneturide.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Pheneturide.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Pheneturide.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Pheneturide.
Methysergide The risk or severity of CNS depression can be increased when Methysergide is combined with Pheneturide.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Pheneturide.
Phenytoin The risk or severity of CNS depression can be increased when Phenytoin is combined with Pheneturide.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Pheneturide.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Pheneturide.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Pheneturide.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Pheneturide.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Pheneturide.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Pheneturide.
Pentobarbital The risk or severity of CNS depression can be increased when Pentobarbital is combined with Pheneturide.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Pheneturide.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Pheneturide.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Pheneturide.
Dihydroergotamine The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Pheneturide.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Pheneturide.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Pheneturide.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Pheneturide.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Pheneturide.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Pheneturide.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Pheneturide.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Pheneturide.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Pheneturide.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Laburide

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul